--Eni Reduces Personnel at Zubair Oil Field in Iraq as Precautionary Move, Reuters Reports-March 2024-www.financetom.com

--Eni Reduces Personnel at Zubair Oil Field in Iraq as Precautionary Move, Reuters Reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Eni Reduces Personnel at Zubair Oil Field in Iraq as Precautionary Move, Reuters Reports

Jun 23, 2025 8:42 AM

11:16 AM EDT, 06/23/2025 (MT Newswires) --

Price: 32.96, Change: +0.03, Percent Change: +0.09

Previous page： Advent to buy Ryan Reynolds-backed fintech Nuvei in $6.3 bln deal Next page： Fitch expects Change Healthcare hack to have no credit impact on not-for-profit hospitals

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Advent to buy Ryan Reynolds-backed fintech Nuvei in $6.3 bln deal

Apr 1, 2024

April 1 - Private equity firm Advent International has agreed to buy Canada's Nuvei ( NVEI ) in a deal that values the payments technology firm, which has received financial backing from actor Ryan Reynolds, at $6.3 billion. ...

Fitch expects Change Healthcare hack to have no credit impact on not-for-profit hospitals

Apr 1, 2024

April 1 (Reuters) - Ratings agency Fitch said on Monday that it does not anticipate any credit impact on not-for-profit hospitals in the United States from the cyberattack at UnitedHealth's ( UNH ) Change Healthcare unit. ...

--Nuvei Agrees to be Taken Private by Advent International

Apr 1, 2024

12:36 PM EDT, 04/01/2024 (MT Newswires) -- Price: 33.32, Change: +1.70, Percent Change: +5.38 ...

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease

Apr 1, 2024

Thursday, the FDA extended the review period for Applied Therapeutics Inc’s New Drug Application (NDA) for govorestat (AT-007) for the treatment of Classic Galactosemia by three months. The FDA has set a new Prescription Drug User Fee Act (PDUFA) target action date of November 28, 2024, from the initial date of August 28, 2024. The FDA notified Applied Therapeutics ( APLT ) that it...